Blog
Randomised Controlled Trial: Improvements in side effects of metastatic sarcoma patients (ASCO 2025)
SARC-Digital is a Randomised Controlled Trial (RCT) focusing on our personalised patient support solution, specifically for patients with advanced or metastatic sarcoma. The trial’s interim results were shared with the scientific community at the annual meeting of the American Society for Clinical Oncology (ASCO) through an abstract highlighting its findings.
Positive final results of Randomised Controlled Trial on Quality of Life presented orally at ASCO 2025
After the presentation on interim results in 2024, this year the Trial’s final results were presented, highlighting the impact of our solution on cancer patients’ quality of life and healthcare costs.
Long-term side-effect improvement: RCT results showcased at ESMO 2024
The prospective randomised controlled trial on advanced or metastatic non-small cell lung cancer (NSCLC) patients showed long-term reduction of side-effects, in a poster presented at ESMO 2024.
Results from CareAcross Randomised Controlled Trial presented orally at ASCO 2024
At the 2024 ASCO congress, promising results of the prospective randomised controlled trial (RCT) conducted through the CareAcross service were shared in a mini-oral presentation.
Enhanced quality of life via digital support to advanced NSCLC patients (ESMO 2023 poster)
We presented the interim analysis of a randomised clinical trial, showcasing improved patient quality of life, and illustrating the patient experience via real world data.
CareAcross at ASCO 23: Using Patient-Reported Outcomes (PROs) to understand Cancer-Related Thrombosis
Explore the power of patient-reported outcomes (PROs) in understanding cancer-related thrombosis. CareAcross abstract from the American Society of Clinical Oncology (ASCO) congress in Chicago.
Real World Data from Lung Cancer patients presented at WCLC 2022
Two abstracts featuring real world data presented at WCLC 22: Comparing side-effects between past/current smokers and never smokers; and examining differences in toxicity among platinum-based combinations.
CareAcross poster on Quality of Life interventions presented at ASCO 2022
Cancer-related fatigue is a common experience of cancer patients. We showcased the effectiveness of our personalised interventions at the American Society of Clinical Oncology (ASCO) congress in Chicago.
CareAcross Posters presented at ESMO Breast Cancer 2022
The company shared 2 posters based on real world data analysis from thousands of breast cancer patients. The findings focused on Aromatase Inhibitors and their side-effects, as well as comorbidities and their correlations with metastatic, hormonal and HER2 status.
Immunotherapy: low awareness revealed from CareAcross research among 5589 cancer patients
What do patients know and believe about immunotherapy? CareAcross conducted an extensive study collecting responses from 5,589 cancer patients.
Patient perceptions on Immunotherapy, Support needs, and Medication Adherence presented at the World Conference on Lung Cancer 2021
CareAcross presented real world evidence from cancer patients as reported through the CareAcross platform, in the form of 3 posters, including a featured poster on lung cancer patients’ perceptions on immunotherapy.
HER2-positive breast cancer: foods to eat or avoid
A breast cancer diagnosis comes with a long list of things to worry about. For many women, some of them include diet and nutrition.
CareAcross posters presented at ASCO 2021
The 2021 Annual Congress of the American Society of Clinical Oncology (ASCO) took place in early June. This year, as in 2020, the conference took place virtually and not in Chicago, and therefore the expected crowd of 45,000 attended keynotes and lectures, and viewed abstracts and posters, from across the globe.
Positive Results Of Digital Engagement On Cancer Patients' Quality Of Life
Analysis of cancer patients' engagement on CareAcross online platforms shows reduced number of side-effects
Complementary and Alternative Medicine in Cancer: Patient survey results (perceptions and preferences)
CareAcross announced today the results of a survey it recently carried out among cancer patients, offering enhanced insight on the perceptions of patients regarding complementary and alternative medicine (CAM).
Improving participation in cancer clinical trials
Clinical Trials are the cornerstone of research activities for new ways to treat cancer. Unfortunately, many barriers prevent patients from learning about, and participating in clinical trials. Our Chief Medical Officer weighs in.
On breast cancer and certainty: Some myths to consider
A BRCA gene mutation and a mammogram do not always have definite outcomes. Similarly, it is not always definite that a breast abnormality is directly life-threatening.
Abortion, implants, and - could needle biopsies promote breast cancer?
Does the biopsy needle help cancer spread? Do abortions increase breast cancer risk? What about family history? How do implants affect doctors’ ability to diagnose a breast tumour? More myths being dispelled!
Mammogram radiation risks, fertility treatments, family history and breast cancer
Could annual mammograms cause breast cancer? What about fertility treatments with hormones? Is a breast tumour preventable if there is no history in the family?
Fruits and vegetables for cancer patients
What is it about fruits and vegetables that make them necessary? What is the research behind their benefits? And how can they help those diagnosed with cancer?
Psychological support can make a difference
When a cancer diagnosis strikes, the first step is to use medications, radiation therapy or surgery to treat it. However, many patients seem to forget how their own psychology can affect how they deal with cancer every day.
Fish protects and strengthens against breast cancer
You probably know that you are supposed to eat fish regularly. However, you might not know the many different ways that fish benefits our health.
Are you getting enough vitamin D?
Vitamin D is special, as it does not only come from food, but also the sun. Researchers recently published a map of vitamin D deficiency across Europe, which could make you think about your own vitamin D levels.
Headaches and seizures, finishing treatment, and more brain tumor myths
Are headaches and seizures certain symptoms of brain cancer? What happens after treatment? Are benign brain tumors "safe"? Let's learn more about this condition.
It is a cloudy day - time to apply some sunscreen
Read why we should protect our skin even on cloudy days, how parts with less exposure to the sun could get skin cancer, and whether you are spending too much time in the sun.
Hair dye and brain cancer, treatment options, benign tumors and other myths
Do hair-coloring chemicals cause brain tumors? When it comes to treatments, is surgery the only option? What about a benign tumor? Read about some common myths.
Melanoma risk for people with darker skin and more skin cancer myths
Skin cancer is usually caused by the sun’s rays. Melanoma is skin cancer’s most serious type. Let’s explore myths about dark skin, whether little sun exposure can harm, and sunscreen.
Myths on skin cancer in older people, sunscreen protection and more
How are skin cancer and melanoma related to sunscreen protection, outdoor activities, or the colour of our skin? Read on and find out how to sun-proof and age-proof your skin.
True or false - Skin type, suspicious moles, tanning beds and more myths
Am I protected from UV radiation on rainy days? Should I use tanning beds? Could my "harmless" mole be cancerous? Here are 5 myths that deserve to be discussed.
How much sunscreen is enough, sun protection, UVB radiation, and more myths
Skin cancer and melanoma (its most serious type) are linked with exposure to the sun’s rays. What should your sunscreen’s Sun Protection Factor (SPF) be? If you are already tanned, are you protected?